lenalidomide has been researched along with Diffuse Parenchymal Lung Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aljohani, NI; Nawaz, A; Rehman, JU; Shafi, A | 1 |
| Ihara, K; Inomata, H; Kato, J; Kikuchi, S; Koyama, R; Muramatsu, H; Nagamachi, Y; Nishisato, T; Nozawa, E; Okamoto, T; Ono, K; Tanaka, S; Yamada, H; Yamauchi, N; Yano, T | 1 |
| Cabrera César, E; Fernández Aguirre, MC; González Fernández, A | 1 |
| Chen, Y; Kiatsimkul, P; Nugent, K; Raj, R | 1 |
| Iino, M | 1 |
| Arita, M; Hotta, M; Ishida, T; Kunimasa, K; Maeda, T; Ueda, T | 1 |
2 review(s) available for lenalidomide and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Safety and effectiveness of low-dose lenalidomide therapy for multiple myeloma complicated with bortezomib-associated interstitial pneumonia.
Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Immunologic Factors; Lenalidomide; Lung Diseases, Interstitial; Multiple Myeloma; Pyrazines; Thalidomide; Treatment Outcome | 2013 |
Drug-induced interstitial pneumonitis due to low-dose lenalidomide.
Topics: Aged; Antineoplastic Agents; Humans; Lenalidomide; Lung Diseases, Interstitial; Male; Thalidomide | 2012 |
4 other study(ies) available for lenalidomide and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Lenalidomide-induced Interstitial Pneumonitis.
Topics: Humans; Lenalidomide; Lung Diseases, Interstitial | 2020 |
Lung Toxicity after Lenalidomide Treatment in a Patient with Multiple Myeloma.
Topics: Dexamethasone; Glucocorticoids; Humans; Immunologic Factors; Lenalidomide; Lung Diseases, Interstitial; Male; Middle Aged; Multiple Myeloma; Recurrence; Thalidomide | 2017 |
Lenalidomide-induced interstitial lung disease.
Topics: Aged; Antineoplastic Agents; Combined Modality Therapy; Diagnosis, Differential; Dinoprostone; Female; Humans; Lenalidomide; Lung; Lung Diseases, Interstitial; Multiple Myeloma; Thalidomide; Treatment Outcome | 2010 |
Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.
Topics: Antineoplastic Agents; Humans; Immunomodulation; Immunosuppressive Agents; Lenalidomide; Lung Diseases, Interstitial; Male; Middle Aged; Multiple Myeloma; Radiography; Thalidomide | 2012 |